This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zheng, H. Articles by Cornelius, L. A. Search for Related Content PubMed PubMed Citation Articles by Zheng, H. Articles by Cornelius, L. A.

Down-regulation of Rap1GAP via Promoter Hypermethylation Promotes Melanoma Cell Proliferation, Survival, and Migration

Divisions of ¹ Dermatology and ² Hematology, Department of Internal Medicine, ³ Department of Neurological Surgery, and ⁴ Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri

Requests for reprints: Lynn A. Cornelius, Division of Dermatology, Department of Internal Medicine, Washington University School of Medicine, 660 South Euclid, St. Louis, MO 63110. Phone: 314-362-8187; Fax: 314-362-8159; E-mail: cornelil{at}msnotes.wustl.edu.

Key Words: Rap1GAP • melanoma • methylation • Rap1

Melanoma is the most serious, highly aggressive form of skin cancer with recent dramatic increases in incidence. Current therapies are relatively ineffective, highlighting the need for a better understanding of the molecular mechanisms contributing to the disease. We have previously shown that activation of Rap1 promotes melanoma cell proliferation and migration through the mitogen-activated protein kinase pathway and integrin activation. In the present study, we show that expression of Rap1GAP, a specific negative regulator of Rap1, is decreased in human melanoma tumors and cell lines. Overexpression of Rap1GAP in melanoma cells blocks Rap1 activation and extracellular signal-regulated kinase (ERK) phosphorylation and inhibits melanoma cell proliferation and survival. In addition, overexpression of Rap1GAP also inhibits focal adhesion formation and decreases melanoma cell migration. Rap1GAP down-regulation is due to its promoter methylation, a mechanism of gene silencing in tumors. Furthermore, treatment of melanoma cells with the demethylating agent 5-aza-2'-deoxycytidine reinduces Rap1GAP expression, followed by decreased Rap1 activity, ERK phosphorylation, and cell proliferation and survival—changes that are significantly blunted in cells transfected by small interfering RNA–mediated Rap1GAP knockdown. Taken together, our findings indicate that down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration. [Cancer Res 2009;69(2):449–57]